National Institute of Neurological Disorders and Stroke; Notice of Closed Meetings, 12458-12459 [2017-04078]
Download as PDF
12458
Federal Register / Vol. 82, No. 41 / Friday, March 3, 2017 / Notices
appropriate advisory committee meeting
link, or call the advisory committee
information line to learn about possible
modifications before coming to the
meeting.
mstockstill on DSK3G9T082PROD with NOTICES
SUPPLEMENTARY INFORMATION:
Agenda: The committees will discuss
safety issues associated with over-thecounter analgesic combination products
used for upset stomach (i.e., heartburn,
nausea, fullness, belching, gas, acid
indigestion, and/or sour stomach) and
hangover indications under the Internal
Analgesic and Antacid monographs in
21 CFR part 343 and 21 CFR part 331,
respectively. The committees will also
be asked to discuss the hangover
indication under the Overindulgence,
Internal Analgesic, and Stimulant
monographs in 21 CFR part 357 subpart
J, 21 CFR part 343, and 21 CFR part 340,
respectively.
FDA intends to make background
material available to the public no later
than 2 business days before the meeting.
If FDA is unable to post the background
material on its Web site prior to the
meeting, the background material will
be made publicly available at the
location of the advisory committee
meeting, and the background material
will be posted on FDA’s Web site after
the meeting. Background material is
available at https://www.fda.gov/
AdvisoryCommittees/Calendar/
default.htm. Scroll down to the
appropriate advisory committee meeting
link.
Procedure: Interested persons may
present data, information, or views,
orally or in writing, on issues pending
before the committees. All electronic
and written submissions submitted to
the Docket (see the ADDRESSES section)
on or before March 21, 2017, will be
provided to the committees. Oral
presentations from the public will be
scheduled between approximately 1
p.m. and 2 p.m. Those individuals
interested in making formal oral
presentations should notify the contact
person and submit a brief statement of
the general nature of the evidence or
arguments they wish to present, the
names and addresses of proposed
participants, and an indication of the
approximate time requested to make
their presentation on or before March
13, 2017. Time allotted for each
presentation may be limited. If the
number of registrants requesting to
speak is greater than can be reasonably
accommodated during the scheduled
open public hearing session, FDA may
conduct a lottery to determine the
speakers for the scheduled open public
hearing session. The contact person will
VerDate Sep<11>2014
16:42 Mar 02, 2017
Jkt 241001
notify interested persons regarding their
request to speak by March 14, 2017.
Persons attending FDA’s advisory
committee meetings are advised that the
Agency is not responsible for providing
access to electrical outlets.
FDA is establishing a docket for
public comment on this meeting. The
docket number is FDA–2017–N–0965.
The docket will close on April 3, 2017.
Comments received on or before March
21, 2017, will be provided to the
committees. Comments received after
that date will be taken into
consideration by the Agency.
FDA welcomes the attendance of the
public at its advisory committee
meetings and will make every effort to
accommodate persons with disabilities.
If you require accommodations due to a
disability, please contact Moon Hee V.
Choi at least 7 days in advance of the
meeting.
FDA is committed to the orderly
conduct of its advisory committee
meetings. Please visit our Web site at
https://www.fda.gov/
AdvisoryCommittees/
AboutAdvisoryCommittees/
ucm111462.htm for procedures on
public conduct during advisory
committee meetings.
Notice of this meeting is given under
the Federal Advisory Committee Act (5
U.S.C. app. 2).
Dated: February 28, 2017.
Janice M. Soreth,
Associate Commissioner for Special Medical
Programs.
[FR Doc. 2017–04152 Filed 3–2–17; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
PO 00000
Frm 00032
Fmt 4703
Sfmt 4703
Name of Committee: National Institute of
Neurological Disorder and Stroke Special
Emphasis Panel; BRAIN: Large Scale
Recording and Neuromodulation.
Date: March 27–28, 2017.
Time: 8:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road NW.,
Washington, DC 20015.
Contact Person: Shanta Rajaram, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, NINDS/NIH/DHHS, Neuroscience
Center, 6001 Executive Blvd., Suite 3204,
MSC 9529, Bethesda, MD 20892–9529, (301)
496–6033, rajarams@mail.nih.gov.
Name of Committee: National Institute of
Neurological Disorder and Stroke Special
Emphasis Panel; Program Project Grant P01.
Date: March 30, 2017.
Time: 11:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Virtual
Meeting).
Contact Person: Ana Olariu, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, NINDS/NIH/DHHS, Neuroscience
Center, 6001 Executive Blvd., Suite 3204,
MSC 9529, Bethesda, MD 20892–9529, (301)
496–9223, Ana.Olariu@nih.gov.
Name of Committee: National Institute of
Neurological Disorder and Stroke Special
Emphasis Panel; Leveraging Existing
Resources for Research on Lewy Body
Dementia.
Date: April 7, 2017.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Virtual
Meeting).
Contact Person: Ernest Lyons, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, NINDS/NIH/DHHS, Neuroscience
Center, 6001 Executive Blvd., Suite 3204,
MSC 9529, Bethesda, MD 20892–9529, (301)
496–0182, lyonse@ninds.nih.gov.
Name of Committee: National Institute of
Neurological Disorder and Stroke Special
Emphasis Panel; Training and Career
Development Application Review.
Date: April 10, 2017.
Time: 1:30 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Telephone
Conference Call).
Contact Person: Elizabeth A. Webber,
Ph.D., Scientific Review Officer, Scientific
Review Branch, NINDS/NIH/DHHS,
Neuroscience Center, 6001 Executive Blvd.,
Suite 3204, MSC 9529, Bethesda, MD 20892–
9529, (301) 496–1719, webbere@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
E:\FR\FM\03MRN1.SGM
03MRN1
Federal Register / Vol. 82, No. 41 / Friday, March 3, 2017 / Notices
Neurosciences, National Institutes of Health,
HHS)
Dated: February 27, 2017.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–04078 Filed 3–2–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the National Cancer
Institute Board of Scientific Advisors,
March 21, 2017, 8:30 a.m. to March 22,
2017, 12:00 p.m., National Institutes of
Health, Building 31 Center Drive,
Conference Room 6, Bethesda, MD
20892 which was published in the
Federal Register on February 22, 2017,
82 FR 11363.
The meeting notice is amended to
change the meeting date to March 21,
2017. The location and time remain the
same. The meeting is open to the public.
Date: April 13, 2017.
Time: 2:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Institute on Alcohol Abuse and
Alcoholism, 5635 Fishers Lane, Bethesda,
MD 20892 (Telephone Conference Call).
Contact Person: Philippe Marmillot, Ph.D.,
National Institutes of Health, National
Institute on Alcohol Abuse and Alcoholism,
5635 Fishers Lane, Rm 2017, Bethesda, MD
20892, 301–443–2861, marmillotp@
mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.271, Alcohol Research
Career Development Awards for Scientists
and Clinicians; 93.272, Alcohol National
Research Service Awards for Research
Training; 93.273, Alcohol Research Programs;
93.891, Alcohol Research Center Grants;
93.701, ARRA Related Biomedical Research
and Research Support Awards, National
Institutes of Health, HHS)
Dated: February 27, 2017.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
12459
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the National Cancer
Institute Special Emphasis Panel, March
8, 2017, 12:00 p.m. to March 8, 2017,
04:00 p.m., National Cancer Institute
Shady Grove, 9609 Medical Center
Drive, 7W110, Rockville, MD, 20850
which was published in the Federal
Register on December 29, 2016, 81 FR
96029.
The meeting notice is amended to
change the date and time of the meeting
to March 30, 2017 from 12:30 p.m. to
4:00 p.m. The meeting is closed to the
public.
Dated: February 27, 2017.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–04076 Filed 3–2–17; 8:45 am]
BILLING CODE 4140–01–P
[FR Doc. 2017–04077 Filed 3–2–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: February 27, 2017.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
[FR Doc. 2017–04074 Filed 3–2–17; 8:45 am]
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
National Cancer Institute; Amended
Notice of Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
mstockstill on DSK3G9T082PROD with NOTICES
National Institute on Alcohol Abuse
and Alcoholism; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Notice is hereby given of a change in
the meeting of the National Cancer
Institute Special Emphasis Panel, March
7, 2017, 12:00 p.m. to March 7, 2017,
4:00 p.m., National Cancer Institute
Shady Grove, 9609 Medical Center
Drive, 7W110, Rockville, MD, 20850
which was published in the Federal
Register on December 29, 2016, 81 FR
96029.
The meeting notice is amended to
change the date and time of the meeting
to March 28, 2017 from 11:00 a.m. to
2:00 p.m. The meeting is closed to the
public.
Dated: February 27, 2017.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–04075 Filed 3–2–17; 8:45 am]
BILLING CODE 4140–01–P
Name of Committee: National Institute on
Alcohol Abuse and Alcoholism Special
Emphasis Panel; AA–1 and AA–4 Conflict
Applications.
VerDate Sep<11>2014
16:42 Mar 02, 2017
Jkt 241001
PO 00000
Frm 00033
Fmt 4703
Sfmt 4703
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Genomics and Epigenomics Studies
and Tools Development.
Date: March 22, 2017.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Methode Bacanamwo,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2200,
E:\FR\FM\03MRN1.SGM
03MRN1
Agencies
[Federal Register Volume 82, Number 41 (Friday, March 3, 2017)]
[Notices]
[Pages 12458-12459]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-04078]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Neurological Disorders and Stroke; Notice
of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Neurological Disorder
and Stroke Special Emphasis Panel; BRAIN: Large Scale Recording and
Neuromodulation.
Date: March 27-28, 2017.
Time: 8:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military
Road NW., Washington, DC 20015.
Contact Person: Shanta Rajaram, Ph.D., Scientific Review
Officer, Scientific Review Branch, NINDS/NIH/DHHS, Neuroscience
Center, 6001 Executive Blvd., Suite 3204, MSC 9529, Bethesda, MD
20892-9529, (301) 496-6033, rajarams@mail.nih.gov.
Name of Committee: National Institute of Neurological Disorder
and Stroke Special Emphasis Panel; Program Project Grant P01.
Date: March 30, 2017.
Time: 11:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Neuroscience Center, 6001
Executive Boulevard, Rockville, MD 20852 (Virtual Meeting).
Contact Person: Ana Olariu, Ph.D., Scientific Review Officer,
Scientific Review Branch, NINDS/NIH/DHHS, Neuroscience Center, 6001
Executive Blvd., Suite 3204, MSC 9529, Bethesda, MD 20892-9529,
(301) 496-9223, Ana.Olariu@nih.gov.
Name of Committee: National Institute of Neurological Disorder
and Stroke Special Emphasis Panel; Leveraging Existing Resources for
Research on Lewy Body Dementia.
Date: April 7, 2017.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Neuroscience Center, 6001
Executive Boulevard, Rockville, MD 20852 (Virtual Meeting).
Contact Person: Ernest Lyons, Ph.D., Scientific Review Officer,
Scientific Review Branch, NINDS/NIH/DHHS, Neuroscience Center, 6001
Executive Blvd., Suite 3204, MSC 9529, Bethesda, MD 20892-9529,
(301) 496-0182, lyonse@ninds.nih.gov.
Name of Committee: National Institute of Neurological Disorder
and Stroke Special Emphasis Panel; Training and Career Development
Application Review.
Date: April 10, 2017.
Time: 1:30 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Neuroscience Center, 6001
Executive Boulevard, Rockville, MD 20852 (Telephone Conference
Call).
Contact Person: Elizabeth A. Webber, Ph.D., Scientific Review
Officer, Scientific Review Branch, NINDS/NIH/DHHS, Neuroscience
Center, 6001 Executive Blvd., Suite 3204, MSC 9529, Bethesda, MD
20892-9529, (301) 496-1719, webbere@mail.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.853,
Clinical Research Related to Neurological Disorders; 93.854,
Biological Basis Research in the
[[Page 12459]]
Neurosciences, National Institutes of Health, HHS)
Dated: February 27, 2017.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-04078 Filed 3-2-17; 8:45 am]
BILLING CODE 4140-01-P